College of Chinese Medicine, Jinan University, Guangzhou, Guangdong, China (mainland).
Med Sci Monit. 2021 Apr 29;27:e930552. doi: 10.12659/MSM.930552.
BACKGROUND Hypertension-related microRNA(miR)-1283 and its target gene, activating transcription factor-4 (ATF4), can regulate vascular endothelial dysfunction. This study aimed to explore whether miR-1283 prevents hypertension through targeting ATF4. MATERIAL AND METHODS Transcriptome sequencing was performed after overexpression or inhibition of miR-1283 in human amniotic epithelial cells (HAECs). After miR-1283 was overexpressed or inhibited in HAECs, ATF4+/- and wild-type mice were induced with a high-salt diet. We detected the expression of ATF4, C/EBP-homologous protein (CHOP), BH3-interacting domain death agonist (BID), Bcl-2, Bcl-2-like protein 11 (BIM), Bcl-2-like protein 1 (BCL-X), and caspase-3 by PCR and western blotting. We detected the changes of vasoactive substances including nitric oxide (NO), endothelin 1 (ET-1), endothelial protein C receptor (EPCR), thrombin (TM), and von Willebrand factor (vWF) by ELISA. RESULTS Compared with that of the miR-1283- inhibited group, NO was higher in the miR-1283 overexpression group, while the expression of ET-1, EPCR, TM, and vWF were lower. Similarly, compared with that of the miR-1283 inhibited group, the expression of ATF4, CHOP, BID, BIM, and caspase-3 in the miR-1283 overexpression group was downregulated, while the expression of BCL-2 and BCL-X was upregulated (P<0.05). In vivo experiments showed the lack of ATF4 gene could prevent hypertension in mice induced by high-salt diet and protect endothelial function. CONCLUSIONS The mechanism of regulating blood pressure and endothelial function of the miR-1283/ATF4 axis was related to inhibiting endoplasmic reticulum stress and cell apoptosis through the ATF4/CHOP signaling pathway. Therefore, the miR-1283/ATF4 axis may be a target for the prevention and treatment of hypertension.
高血压相关 microRNA(miR)-1283 及其靶基因激活转录因子 4(ATF4)可调节血管内皮功能障碍。本研究旨在探讨 miR-1283 是否通过靶向 ATF4 预防高血压。
在人羊膜上皮细胞(HAECs)中转录组测序后,过表达或抑制 miR-1283。在 HAECs 中过表达或抑制 miR-1283 后,用高盐饮食诱导 ATF4+/-和野生型小鼠。我们通过 PCR 和 Western blot 检测 ATF4、C/EBP 同源蛋白(CHOP)、BH3 相互作用域死亡激动剂(BID)、Bcl-2、Bcl-2 样蛋白 11(BIM)、Bcl-2 样蛋白 1(BCL-X)和半胱天冬酶-3 的表达。通过 ELISA 检测包括一氧化氮(NO)、内皮素 1(ET-1)、内皮蛋白 C 受体(EPCR)、凝血酶(TM)和血管性血友病因子(vWF)在内的血管活性物质的变化。
与 miR-1283 抑制组相比,miR-1283 过表达组的 NO 升高,而 ET-1、EPCR、TM 和 vWF 的表达降低。同样,与 miR-1283 抑制组相比,miR-1283 过表达组的 ATF4、CHOP、BID、BIM 和 caspase-3 表达下调,而 BCL-2 和 BCL-X 的表达上调(P<0.05)。体内实验表明,敲除 ATF4 基因可预防高盐饮食诱导的小鼠高血压,保护内皮功能。
miR-1283/ATF4 轴调节血压和内皮功能的机制与通过 ATF4/CHOP 信号通路抑制内质网应激和细胞凋亡有关。因此,miR-1283/ATF4 轴可能是高血压防治的靶点。